在BRAF突变的晚期结直肠癌中,免疫检查点抑制剂
Rebecca Kassab1, Michel Abou Khalil1, Joseph Kassab1
1Department of Hematology & Oncology, Saint Joseph University, Beirut, Lebanon.
Future oncology (London, England)
|November 22, 2023
概括
BRAF突变的结直肠癌具有挑战性,但免疫疗法提供了新的希望. 像潘布罗利祖马布和尼沃卢马布这样的药物显示出有希望的结果,可能导致一线治疗.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 结肠直肠癌 (CRC) 仍然是一个重大的健康挑战.
- 瘤异质性,特别是BRAF突变,在晚期的CRC中存在治疗困难.
- 标准化疗 (FOLFOX,capecitabine) 在BRAF突变的CRC中显示出有限的疗效.
研究的目的:
- 审查免疫治疗在BRAF突变的先进结直肠癌中的疗效.
- 探索免疫疗法的潜力,作为这种患者子组的前线治疗.
主要方法:
- 临床试验数据的系统审查.
- 对研究免疫治疗药物 (pembrolizumab,nivolumab) 的研究结果的分析.
主要成果:
- 免疫疗法药物,包括pembrolizumab和nivolumab,在患有BRAF突变晚期CRC的患者中显示出有前途的结果.
- 与标准疗法相比,这些药物显示出更高的生存率.
- BRAF突变状态是影响治疗反应的关键因素.
结论:
- 免疫疗法代表了BRAF突变的晚期结直肠癌的重大进展.
- 布罗利祖马布和尼沃卢马布显示出前线治疗的潜力,提供了一个新的治疗途径.
- 需要进一步的研究来优化CRC的免疫疗法策略.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
01:27Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K